Atlantic Technology Ventures, Inc. 150 Broadway, Suite 1009 New York, New York 10038Convertible Preferred Stock and Warrants Purchase Agreement • April 17th, 2001 • Atlantic Technology Ventures Inc • Pharmaceutical preparations
Contract Type FiledApril 17th, 2001 Company IndustryIt is our understanding that (1) you acknowledge that in item (10) of the definition of "Repurchase Event" in the Convertible Preferred Stock and Warrants Purchase Agreement dated September 28, 2000, between Atlantic Technology Ventures, Inc. ("Atlantic") and the Investors, as amended (the "Purchase Agreement"), all references to "the Company" should be to Optex Ophthalmologics, Inc., the majority-owned subsidiary of Atlantic, and (2) that you waive any Repurchase Event that may be caused by occurrence of the event referenced in item (12) of the definition of Repurchase Event in the Purchase Agreement. To confirm that our understanding is correct, please sign a copy of this letter in the space provided below and send a copy by facsimile to Atlantic at (212) 267-2159.
AMENDMENT NO. 3 to CONVERTIBLE PREFERRED STOCK AND WARRANTS PURCHASE AGREEMENT between Atlantic Technology Ventures, Inc. and the Investors Signatory HeretoConvertible Preferred Stock and Warrants Purchase Agreement • January 24th, 2001 • Atlantic Technology Ventures Inc • Pharmaceutical preparations
Contract Type FiledJanuary 24th, 2001 Company Industry
AMENDMENT NO. 1 to CONVERTIBLE PREFERRED STOCK AND WARRANTS PURCHASE AGREEMENT between Atlantic Technology Ventures, Inc. and the Investors Signatory HeretoConvertible Preferred Stock and Warrants Purchase Agreement • November 20th, 2000 • Atlantic Technology Ventures Inc • Pharmaceutical preparations
Contract Type FiledNovember 20th, 2000 Company Industry